{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:30:05Z","timestamp":1781299805842,"version":"3.54.1"},"reference-count":31,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0378-6323.175919","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T06:07:44Z","timestamp":1454911664000},"page":"135","source":"Crossref","is-referenced-by-count":13,"title":["Topical calcipotriol\/betamethasone dipropionate for psoriasis vulgaris: A systematic review"],"prefix":"10.25259","volume":"82","author":[{"given":"Ru","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Duo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.175919-1","first-page":"377","volume-title":"Global epidemiology of psoriasis: A systematic review of incidence and prevalence","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.175919-2","first-page":"39","volume-title":"Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis","author":"Kragballe","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.175919-3","first-page":"463","volume-title":"Calcipotriol\/betamethasone dipropionate: A review of its use in the treatment of psoriasis vulgaris","author":"Fenton","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0378-6323.175919-4","first-page":"736","volume-title":"Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris","author":"Cunliffe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.175919-5","first-page":"193","volume-title":"Double-blind, right\/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris","author":"Kragballe","year":"1991","journal-title":"Lancet"},{"key":"key-10.4103\/0378-6323.175919-6","doi-asserted-by":"crossref","unstructured":"Shupack JL, Jondreau L, Kenny C, Stiller MJ. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis. Dermatology 1993;186:129-32.","DOI":"10.1159\/000247323"},{"key":"key-10.4103\/0378-6323.175919-7","first-page":"649","volume-title":"Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: Tolerability and efficacy","author":"Kragballe","year":"1998","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-8","first-page":"148","volume-title":"Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: A flow cytometric study","author":"van","year":"2001","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.175919-9","first-page":"361","volume-title":"Efficacy, safety and quality of life of calcipotriol\/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial","author":"Saraceno","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0378-6323.175919-10","first-page":"1723","volume-title":"Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs.ointment formulations in psoriasis vulgaris: 4-and 12-week interim results from the PRO-long study","author":"Lambert","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.175919-11","first-page":"613","volume-title":"Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test","author":"Queille-Roussel","year":"2012","journal-title":"Clin Drug Investig"},{"key":"key-10.4103\/0378-6323.175919-12","first-page":"131","volume-title":"A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris","author":"Douglas","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.175919-13","first-page":"465","volume-title":"Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: A randomised, parallel group, double-blind, exploratory study","author":"Fleming","year":"2010","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-14","first-page":"316","volume-title":"Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: A randomized, double-blind, vehicle-controlled clinical trial","author":"Guenther","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-15","first-page":"691","volume-title":"Caleipotriol betamemasone ointment in the treatment of psoriasis vulgaris: A randomized, double-blind, active-controlled, parallel group study","author":"Huang","year":"2009","journal-title":"Chin J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-16","first-page":"389","volume-title":"A new calcipotriol\/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris","author":"Kaufmann","year":"2002","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.175919-17","first-page":"1167","volume-title":"Efficacy of once-daily treatment regimens with calcipotriol\/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris","author":"Kragballe","year":"2004","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-18","first-page":"1851","volume-title":"Efficacy safety and quality of life of topical calcipotriol betamethasone dipropionate in treatment of psoriasis vulgaris","author":"Mellyanawati","year":"2014","journal-title":"Chongqing Medicine"},{"key":"key-10.4103\/0378-6323.175919-19","first-page":"92","volume-title":"Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: A randomized, double-blind, vehicle-controlled trial","author":"Menter","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.175919-20","first-page":"48","volume-title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis","author":"Papp","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.175919-21","first-page":"d5928","volume-title":"The cochrane collaboration\u2032s tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key-10.4103\/0378-6323.175919-22","first-page":"22","volume-title":"Expert recommendations: The use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis","author":"Daud\u00e9n","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.175919-23","first-page":"10","volume-title":"Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp","author":"Kragballe","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.175919-24","first-page":"667","volume-title":"Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: Position paper on evidence and use in daily practice","author":"Augustin","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"key-10.4103\/0378-6323.175919-25","first-page":"CD005028","volume-title":"Topical treatments for chronic plaque psoriasis","author":"Mason","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0378-6323.175919-26","first-page":"954","volume-title":"Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses","author":"Samarasekera","year":"2013","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-27","first-page":"141","volume-title":"Calcipotriol\/betamethasone dipropionate in the treatment of psoriasis vulgaris","author":"Vakirlis","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"key-10.4103\/0378-6323.175919-28","first-page":"225","volume-title":"Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris","author":"van","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/0378-6323.175919-29","first-page":"148","volume-title":"Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: A randomized, controlled clinical trial","author":"Langley","year":"2011","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.175919-30","first-page":"1155","volume-title":"A 52-week randomized safety study of a calcipotriol\/betamethasone dipropionate two-compound product (Dovobet\/Daivobet\/Taclonex) in the treatment of psoriasis vulgaris","author":"Kragballe","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.175919-31","first-page":"581","volume-title":"The DESIRE study - Psoriasis patients\u2032 satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice","author":"Clar\u00e9us","year":"2009","journal-title":"Eur J Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:44:50Z","timestamp":1611917090000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/topical-calcipotriol-betamethasone-dipropionate-for-psoriasis-vulgaris-a-systematic-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["175919"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.175919","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}